Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study


Chow C. K. , Ramasundarahettige C., Hu W., AlHabib K. F. , Avezum A., Cheng X., et al.

LANCET DIABETES & ENDOCRINOLOGY, cilt.6, ss.798-808, 2018 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 6 Konu: 10
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/s2213-8587(18)30233-x
  • Dergi Adı: LANCET DIABETES & ENDOCRINOLOGY
  • Sayfa Sayısı: ss.798-808

Özet

Background Data are scarce on the availability and affordability of essential medicines for diabetes. Our aim was to examine the availability and affordability of metformin, sulfonylureas, and insulin across multiple regions of the world and explore the effect of these on medicine use.